Page last updated: 2024-10-21

edelfosine and Pyrexia

edelfosine has been researched along with Pyrexia in 1 studies

edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.

Research Excerpts

ExcerptRelevanceReference
"Minimal residual disease was measured with flow cytometry using leukemia-associated phenotypes as established at diagnosis."2.71Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burden. ( Feller, N; Jansen-van der Weide, MC; Ossenkoppele, GJ; Schuurhuis, GJ; van der Pol, MA; Westra, GA, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feller, N1
Jansen-van der Weide, MC1
van der Pol, MA1
Westra, GA1
Ossenkoppele, GJ1
Schuurhuis, GJ1

Trials

1 trial available for edelfosine and Pyrexia

ArticleYear
Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burden.
    Experimental hematology, 2005, Volume: 33, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Bone Marrow Purging; Cryopreservation; Decision Making; Female; Fe

2005